Skip to main content
SpringerLink
Log in

Iron isomaltoside reduces resource use and costs of anaemia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. National Health Service

  2. 2016 British pounds

  3. health care resource group

Reference

  • Pollock RF, et al. A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000. ClinicoEconomics and Outcomes Research 2017: 475-483, No. 9, 10 Aug 2017. Available from: URL: https://doi.org/10.2147/CEOR.S139525

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iron isomaltoside reduces resource use and costs of anaemia. PharmacoEcon Outcomes News 785, 19 (2017). https://doi.org/10.1007/s40274-017-4269-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4269-0

Search

Navigation